On March 5, the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made ...
Mar 25, 2019
0
40
A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of ...
Mar 6, 2019
0
449
Allergic reactions can occur without being triggered by an allergen such as grass or birch pollen—it is enough for the patient to be back in the same place where she was previously exposed to the allergen, as researchers ...
May 5, 2020
0
316
A new coronavirus vaccine guards one body part especially vulnerable to infection: the nose.
Feb 9, 2022
0
79
A team of researchers from Germany, Switzerland, Sweden and Australia has found that a substance isolated from roundworm larvae was able to reduce inflammation in the airways of mice. In their paper published in the journal ...
Made infamous as the club drug Special K, ketamine is nowadays being seen as a wonder drug for some folks with hard-to-treat depression.
Dec 29, 2022
0
73
The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission.
Dec 14, 2023
0
105
After uncovering the progression of HIV infection in the brain thanks to a new mathematical model developed by a UAlberta research team, clinicians and researchers are developing a nasal spray to administer drugs more effectively.
Jun 19, 2017
0
61
In recent years, the opioid epidemic has been worsened by the advent of street fentanyl, an illicit version of a powerful prescription painkiller.
Sep 5, 2023
0
16
Those widely available COVID-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants, new University of Virginia collaborative research ...
Jul 19, 2022
0
250
